News
KLA Corporation On Track To Outperform In 2023
While signs of topping within the semiconductor industry are growing, not all segments face the same headwinds, and KLA Corporation (NASDAQ: KLAC) is in the latter group. Reports from Texas
Can Boston Scientific Set Another Net High?
Although the Q1 results sparked a round of profit-taking, Boston Scientific (NYSE: BSX) can set another new all-time high in 2023. The market has been trending higher on a combination of factors
Soft Guidance Shouldn’t Take the Shine Off Enphase Energy Stock
Enphase Energy, Inc. (NASDAQ: ENPH) stock is down 16% in after-hours trading after concerns about softening revenue in the next quarter. On a day when investors were reminded that the banking
It May Finally Be Time To Buy 3M
The bad news is all around, and the media surely amplifies the effects of anything 'bearish' it can get its hands on. With layoffs in the tech sector from companies like Meta Platforms (NASDAQ:
Seagate Technology Stock Shows the Glass May Still Be Half Full
Data storage solutions giant Seagate Technology Holdings PLC (NYSE: STX) stock got smoked due to its disastrous fiscal Q3 2023 earnings report. The company appeared to be nearing the end of its no
Fifth Third Bancorp Remains Buoyant Among Regional Banks
The Silicon Valley Bank bankruptcy shook the regional bank sector as investors panicked and depositors quickly transferred their money to larger financial institutions like JPMorgan Chase & Co.
Why Philip Morris May Continue to Beat the Broader Market?
Shares of Philip Morris International, Inc. (NYSE: PM) are trying to stage a recovery after falling 5% in pre-market trading on April 20. This came after the company reported mixed results in its
EMX Royalty Announces First Quarter 2024 Results
Vancouver, British Columbia, May 13, 2024 (NYSE American: EMX; TSX Venture: EMX; Frankfurt: 6E9) – EMX Royalty Corporation (the “Company” or “EMX”) is pleased
Robex meldet Finanzergebnisse für 2023
QUEBEC CITY, May 03, 2024 (GLOBE NEWSWIRE) -- Robex Resources Inc. („Robex“ oder das „Unternehmen“) (TSXV: RBX) hat heute seine operativen und finanziellen Ergebnisse für das Jahr 2023
Saturn Oil & Gas Inc. Announces Sale of Non-Core Deer Mountain Property
CALGARY, ALBERTA – April 1, 2024 - Saturn Oil & Gas Inc. (TSX: SOIL) (FSE: SMKA) (OTCQX: OILSF) (“Saturn” or the “Company”) is pleased to announce the Company has entered into a definitive
ETC Group lanciert „Best in Class” Ethereum Staking ETP auf XETRA
- Das effizienteste Instrument, um mit ETH-Staking Erträge zu erzielen
- Das kostengünstigste und renditestärkste ETH Staking ETP auf dem Markt
- So konzipiert, dass es die besten Ergebnisse für
Osisko Reports Record 2023 Results and Provides 2024 Guidance and New 5-Year Outlook
Record annual revenues of $247.3 million and record operating cash flows of $187.0 million
Montréal, February 20, 2024 – Osisko Gold Royalties Ltd
Ingredion Incorporated meldet starke Ergebnisse für das vierte Quartal und das Gesamtjahr 2023
- Das ausgewiesene und das bereinigte Betriebsergebnis* stiegen im vierten Quartal 2023 um 29 % bzw. 21 % im Vergleich zum Vorjahreszeitraum.
- Das ausgewiesene und das bereinigte EPS* für das
Saturn Oil & Gas Inc. Announces 145 Million BOE of Reserves and Proved Developed Producing Net Present Value 10% of $1.4 billion
CALGARY, ALBERTA - January 30, 2024 - Saturn Oil & Gas Inc. (TSX: SOIL)(FSE: SMKA)(OTCQX: OILSF) (“Saturn” or the “Company”) is pleased to announce the results of the independent reserves
Original Research: Ionic Rare Earths Ltd. von hanseatic stock publishing UG (haftungsbeschränkt)
Miningscout - Research-Studie zu Ionic Rare Earths Ltd.
Das australische Seltene Erden- Entwicklungsunternehmen Ionic Rare Earths Ltd. (ASX: IXR, WKN: A2P18Q, FSE: 6UH, ISIN: AU0000081341)
Ingredion Incorporated meldet starke Geschäftsergebnisse für das dritte Quartal und erhöht seine Prognose für das Gesamtjahr
- Das ausgewiesene und das bereinigte Betriebsergebnis* stiegen im dritten Quartal 2023 um 17 % bzw. 15 % im Vergleich zum Vorjahreszeitraum
- Das ausgewiesene und das bereinigte EPS* für das dritte
Merus gibt die Finanzergebnisse für das dritte Quartal 2023 bekannt und informiert über den aktuellen Geschäftsverlauf
- Erste vorläufige klinische Daten zu Petosemtamab in Kombination mit Keytruda in der Erstlinienbehandlung für das 1. Halbjahr 2024 geplant; Aktualisierung der klinischen Daten für die
Data Reveals The States Spending Most On Gambling
- Residents of Maryland are the nation's biggest gamblers averaging a monthly $135 spend per capita
- New Jersey and New York follow in second and third place with per capita monthly spends around
3 Compelling Reasons to Start Buying Undervalued Amazon
Key Points
- Amazon is gaining traction and is expected to continue growing for the foreseeable future.
- Analysts and institutions are buying this stock; analysts see it moving 20% higher.
Investment Research Budgets Slide Again Despite Imminent Rebundling Freedoms
- The average research budget has decreased a further 6.5%
- Payments to the top ten brokers in the average research budget increased to 54.6%, from 53.9% in 2022
- Impact of M&A - Acquired
Hold-It-Forever AutoZone Pulls into Buy Zone
Key Points
- AutoZone is pulling back on solid results and offering another buying opportunity for investors.
- This buy-and-hold stock is leaning into international expansion centered on key
2 Beauty Stocks Beaten By the Ugly Stick But Ready to Rally
Key Points
- Hims & Hers provides a telehealth wellness and beauty platform offering medical consults, sexual health products, and over-the-counter and prescription medications conveniently and
2 Recession-Proof Intelligence Stocks to Defend Your Portfolio
Key Points
- Cognyte is an artificial intelligence (AI) powered intelligence analytics software provider to hundreds of government, intelligence, military and security clients in over 100
3 Reasons Dollar General Shares Belong in the Shopping Cart
Key Points
- Dollar General is facing industry wide constraints such as a rough discretionary spending patch and the impact of organized theft.
- The company is positioning itself to grab more
Why Analysts Say GE’s Healthcare Spinoff Has $20 Upside
Key Points
- GE HealthCare offers a range of medical technologies and pharmaceutical diagnostics to health care clinicians.
- Mergers & acquisitions are a major component of the GE HealthCare